Search results

Jump to navigation Jump to search
Results 1 – 100 of 335
Advanced search

Search in namespaces:

  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  

  • Dosage (category Responsible drug use)
    flexiweigh_balance_accuracy.pdf Scales - TripSit wiki  3-MeO-PCP - TripSit wiki  Responsible drug use index
    5 KB (1,438 words) - 23:18, 21 April 2024
  • Responsible drug use (category Responsible drug use)
    June 16, 2013.  Sharing Drug “Snorting Straws” Spreads Hepatitis C, 2016  Responsible drug use index
    37 KB (3,944 words) - 23:17, 21 April 2024
  • Research chemicals (redirect from Designer drug) (category Responsible drug use)
    (N-Ethylamphetamine) Fencamine Lefetamine MDPV MDPHP Responsible use Research chemical (Wikipedia) Designer drug (Wikipedia) Experimental & Research Chemicals
    19 KB (2,209 words) - 23:08, 21 April 2024
  • Experience index (category PsychonautWiki)
    Progression of Sleep Deprivation Visuals Over Time by Fishcenternicole Edit Responsible use Psychoactive substance index Subjective effects index
    2 KB (4,008 words) - 23:00, 21 April 2024
  • 25x-NBOMe
    25x-NBOMe series are not habit-forming and the desire to use them can actually decrease with use. They are thought to be most often self-regulating. Tolerance
    6 KB (1,847 words) - 00:06, 16 May 2024
  • PCP
    Erowid Experience Vaults: PCP Further information: Responsible use § Hallucinogens The long-term use of PCP may lead to schizophrenia-like psychotic episodes
    25 KB (3,130 words) - 14:33, 16 April 2024
  • 25I-NBOMe
    one use harm reduction practices when using this substance. 25I-NBOMe is not habit-forming and the desire to use it can actually decrease with use. It
    28 KB (4,417 words) - 14:00, 16 April 2024
  • 3-MeO-PCE
    and harm potential, and Responsible use § Hallucinogens The toxicity and long-term health effects of recreational 3-MeO-PCE use do not seem to have been
    20 KB (2,787 words) - 17:34, 17 March 2024
  • 25D-NBOMe
    therapeutic index. 25D-NBOMe has no history of human use prior to being sold online as a designer drug in 2010.[citation needed] Extremely little is known
    19 KB (3,278 words) - 19:48, 19 July 2022
  • 25N-NBOMe
    that one use harm reduction practices when using this drug. 25N-NBOMe is not habit-forming, and the desire to use it can actually decrease with use. It is
    18 KB (3,141 words) - 20:58, 19 July 2022
  • 4-FA
    [citation needed] Virginia: 4-FA is classified as a Schedule I drug.[citation needed] Responsible use Research chemical Entactogen Stimulants Amphetamine MDMA 3-FEA
    21 KB (3,439 words) - 15:42, 30 July 2022
  • Dosage measurement (category Responsible drug use)
    Psychoactives Vault : Basics: The Importance of Measured Doses  Responsible drug use index
    9 KB (1,092 words) - 23:18, 21 April 2024
  • 25B-NBOMe
    substance may be overly difficult to use safely. Therefore it is highly advised to use harm reduction practices if using this substance. 25B-NBOMe or 2C-B-NBOMe
    19 KB (3,287 words) - 22:22, 19 July 2022
  • 25C-NBOMe
    one use harm reduction practices when using this substance. 25C-NBOMe is not habit-forming, and the desire to use it can actually decrease with use. It
    26 KB (4,063 words) - 23:35, 21 April 2024
  • Reagent testing kits (category Responsible drug use) (section How to use reagents)
    that a drug is safe. No drug use is 100% safe. Make wise decisions and take responsibility for your health and well-being; no one else can. Drug checking
    23 KB (1,192 words) - 17:50, 19 March 2024
  • PCE
    Research chemicals § Toxicity and harm potential, and Responsible use § Hallucinogens The long-term use of PCE may lead to schizophrenia-like psychotic episodes
    18 KB (2,543 words) - 21:36, 21 July 2022
  • Main Page (section Responsible drug use)
    classification ⋅ Dosage measurement ⋅ Dosage (Milligram scale) ⋅ Drug overdose ⋅ Drug withdrawal ⋅ HPPD ⋅ List of pharmaceuticals ⋅ Recovery position ⋅
    21 KB (1,004 words) - 23:38, 13 May 2024
  • 3-HO-PCP
    and harm potential, and Responsible use § Hallucinogens The toxicity and long-term health effects of recreational 3-HO-PCP use have not been studied in
    20 KB (2,510 words) - 17:29, 17 March 2024
  • 3-HO-PCE
    and harm potential, and Responsible use § Hallucinogens The toxicity and long-term health effects of recreational 3-HO-PCE use has not been studied in
    16 KB (2,138 words) - 20:47, 21 July 2022
  • Cannabinoid
    carcinogenic. It is strongly recommended that one use harm reduction practices when using these drugs. Please be aware that pre-mixed, branded blends are
    27 KB (3,598 words) - 22:59, 21 April 2024
  • Isomer
    homochiral compound. Responsible use Scientific information Psychoactive substance index Isomer (Wikipedia) https://en.wikipedia.org/wiki/Racemic_mixture |
    7 KB (957 words) - 23:08, 21 April 2024
  • 2C-B
    test. Further information: Responsible use § Hallucinogens The toxicity and long-term health effects of recreational 2C-B use have not been studied in any
    36 KB (4,745 words) - 16:35, 7 April 2024
  • Amphetamine
    amphetamine use, but is unlikely to arise from typical medical use. Tolerance to many of the effects of amphetamine develops with prolonged and repeated use. This
    41 KB (5,610 words) - 19:01, 7 April 2024
  • MDMA (category Pages with citations using unsupported parameters)
    a license from the Drug Enforcement Administration (DEA). Czech Republic: MDMA is a Schedule I controlled substance. Responsible use Entactogen Stimulant
    85 KB (10,499 words) - 14:24, 16 April 2024
  • Synthetic cannabinoid
    disorders not use synthetic cannabinoids. In contrast to most other recreational drugs, the dramatic psychotic state induced by the use of synthetic cannabinoids
    20 KB (2,224 words) - 22:50, 21 April 2024
  • Methamphetamine (category Pages using citations with accessdate and no URL)
    Class A drug as of 18 January 2007. United States: Methamphetamine is a Schedule II controlled substance in the United States. Responsible use Psychoactive
    41 KB (5,798 words) - 13:29, 16 April 2024
  • 3-MeO-PCP
    and harm potential, and Responsible use § Hallucinogens The toxicity and long-term health effects of recreational 3-MeO-PCP use has not been studied in
    25 KB (3,520 words) - 21:44, 6 May 2024
  • Datura
    legitimate medical purposes, a person may not possess or use the plant known as Datura stramonium Responsible use Deliriant Entheogen Tropane alkaloids Diphenhydramine
    26 KB (2,932 words) - 14:16, 16 April 2024
  • Lorazepam
    -bad7-eec855d6162a.pdf Drugs licensing  Drug Scheduling, DEA | https://www.dea.gov/drug-information/drug-scheduling Polish wiki about controlled substances
    22 KB (2,595 words) - 13:26, 16 April 2024
  • 6-APB
    § Toxicity and harm potential, and Responsible use § Hallucinogens Due to only having a short history of human use, the toxicity and harm potential is
    33 KB (4,870 words) - 14:34, 16 April 2024
  • Atropa belladonna
    dangerous and extremely unpleasant experiences. Please use responsible use practices when trying this drug and always have a trip sitter. Atropa belladonna,
    1 KB (155 words) - 14:48, 3 October 2020
  • Thebaine
    listed as a Class A drug under the Misuse of Drugs Act 1971 in the United Kingdom, is controlled as an analog of a Schedule II drug per the Analog Act in
    6 KB (900 words) - 21:25, 29 March 2021
  • MDPV
    strongly recommended that one use harm reduction practices when using this drug. More so than other stimulants, the chronic use of MDPV can be considered highly
    23 KB (3,267 words) - 23:45, 21 April 2024
  • DMT
    to delay or decline the consumption of the drug. It's discouraged to users to make use of anxyolitic drugs to inhibe this effect since the experience can
    58 KB (7,681 words) - 22:15, 14 May 2024
  • Etizolam
    of stopping use abruptly. Due to its high abuse and addiction potential, it is highly advised to use proper harm reduction practices if using this substance
    30 KB (3,506 words) - 14:22, 16 April 2024
  • Experience:60mg 4-AcO-DMT Nonstop Quasi-Orgasmic Objectless Euphoria
    would like to attribute to the fact that I use these substances in far more healthy, balanced and responsible way than I have in times past. The main duration
    7 KB (1,138 words) - 01:16, 8 February 2020
  • 4-FMA
    strongly recommended that one use harm reduction practices when using this substance. As with other stimulants, the chronic use of 4-FMA can be considered
    21 KB (3,467 words) - 16:14, 30 July 2022
  • Flunitrazepam
    alcohol or opioids. It is strongly recommended that one use harm reduction practices when using this drug. The oral LD50 (lethal dose in 50% of the population)
    22 KB (2,689 words) - 20:55, 7 April 2024
  • Special Content Project (category PsychonautWiki)
    of right now. Erowid Bluelight Wiki Tripsit PiHKAL (Online Edition) TiHKAL (Online Edition) Google (i.e. search "xxx drug site:bluelight.org" for better
    7 KB (894 words) - 01:33, 15 April 2017
  • Deliriant
    Mandragora officinarum (Mandrake) Responsible use Hallucinogens Psychedelics Dissociatives Duncan, D., Gold, R. (1982). Drugs and the Whole Person. John Wiley
    11 KB (1,021 words) - 23:00, 21 April 2024
  • Dissociatives
    From PCP to MXE: A comprehensive review of the non-medical use of dissociative drugs. Drug Testing and Analysis, 6(7–8), 614–632. https://doi.org/10.1002/dta
    12 KB (1,097 words) - 02:41, 12 May 2024
  • Entactogen
    IBF5MAP MBDB MDA MDAI MDEA MDMA Mephedrone Methylone MMA MMDA PMA PMMA Responsible use Stimulants Psychedelics Empathy, love, and sociability enhancement MDMA
    6 KB (767 words) - 05:26, 22 September 2023
  • Opioids
    one use harm reduction practices when using this class of substances. Due to the highly euphoric nature of these substances, the recreational use and abuse
    19 KB (2,797 words) - 02:47, 12 May 2024
  • Psychedelic (redirect from Psychedelic drug)
    J. W. (2017). Psychedelic drug use in healthy individuals: A review of benefits, costs, and implications for drug policy. Drug Science, Policy and Law,
    31 KB (3,363 words) - 22:58, 21 April 2024
  • Psychonautics (category PsychonautWiki) (section Distinction from recreational substance use)
    those of ordinary recreational drug use. While typically viewed as some of the most powerful tools for such purposes, the use of mind-altering substances
    8 KB (886 words) - 22:58, 21 April 2024
  • NBx
    N-benzylphenethylamines are not habit-forming and the desire to use them can actually decrease with use. They are thought to be most often self-regulating. Some
    27 KB (1,991 words) - 18:31, 18 September 2022
  • 2C-T-2 (category PsychonautWiki articles needing factual verification from October 2020)
    Toxicity and harm potential, and Responsible use § Hallucinogens The toxicity and long-term health effects of recreational 2C-T-2 use do not seem to have been
    22 KB (2,627 words) - 23:08, 29 May 2021
  • Thienodiazepines
    exhibit withdrawal symptoms with a slow onset and extended duration. Responsible use Depressant Benzodiazepine GABA Thienodiazepine (Wikipedia) Risks of
    11 KB (1,081 words) - 14:57, 27 July 2022
  • Stimulants
    MDEA (MDE) MDMA Methylone (βk-MDMA) PMA PMMA 5-APB 5-MAPB 6-APB 6-APDB Responsible use Psychoactive substance index Entactogens Nootropics Depressants Hallucinogens
    11 KB (1,055 words) - 02:52, 12 May 2024
  • Methoxetamine
    Toxicity and harm potential, and Responsible use § Hallucinogens The toxicity and long-term health effects of recreational MXE use do not seem to have been studied
    23 KB (2,917 words) - 00:54, 19 September 2023
  • Nootropic
    Tianeptine Responsible use Psychoactive substance index Entactogens Stimulants Depressants Hallucinogens Nootropic (Wikipedia) Nootropics / Smart Drugs (Erowid)
    6 KB (658 words) - 23:00, 21 April 2024
  • Benzodiazepines (section Medical uses)
    Benzodiazepines have a unique history in that they were responsible for the largest-ever class-action lawsuit against drug manufacturers in the United Kingdom, involving
    28 KB (3,429 words) - 03:46, 9 May 2024
  • Tramadol
    strongly recommended that one use harm reduction practices when using this drug. As with other opioids, the chronic use of tramadol can be considered moderately
    22 KB (3,211 words) - 19:11, 7 April 2024
  • Alcohol (redirect from Alcohol use disorder) (category Pages with citations using unsupported parameters) (section Recreational use)
    generally discourage the use or consumption of alcohol. Spiritual: See the spiritual section. Recreational use: Recreational drug use of alcohol in moderation
    95 KB (11,688 words) - 02:47, 12 May 2024
  • Needle distribution programs (category Responsible drug use)
    Diego, CA 92104. Safer injection guide Sharing injection materials Responsible use Routes of administration North America Syringe Exchange Network Javed
    1 KB (230 words) - 19:22, 3 September 2022
  • ΑMT
    Toxicity and harm potential, and Responsible use § Hallucinogens The toxicity and long-term health effects of recreational αMT use do not seem to have been studied
    25 KB (2,825 words) - 16:14, 28 November 2022
  • Cocaine
    cocaine use but is unlikely to arise from typical medical use. Tolerance to many of the effects of cocaine develops with prolonged and repeated use. This
    47 KB (6,322 words) - 08:08, 3 May 2024
  • Mescaline
    one use harm reduction practices when using this substance. Mescaline is not habit-forming, and the desire to use it can actually decrease with use. It
    35 KB (3,957 words) - 06:11, 30 June 2022
  • Rolicyclidine
    Erowid Experience Vaults: PCP Further information: Responsible use § Hallucinogens The long-term use of substances of the PCP class may lead to schizophrenia-like
    21 KB (2,634 words) - 00:21, 11 December 2023
  • Ayahuasca
    one use harm reduction practices when using this substance. Ayahuasca is not habit-forming, and the desire to use it can actually decrease with use. It
    33 KB (3,884 words) - 07:33, 16 November 2023
  • Methaqualone
    Verzeichnis A. Medicinal use is permitted. United Kingdom: Methaqualone is a Class B drug. United States: Methaqualone is a Schedule I drug, and is illegal to
    12 KB (1,829 words) - 23:50, 21 April 2024
  • GHB
    time the drug was used for. Light to moderate users often experience anxiety, insomnia, sleep-related problems, and tremors whereas heavy use can cause
    35 KB (4,460 words) - 13:32, 16 April 2024
  • Methylone
    Psychosis very rarely arises from therapeutic use. Warning: Many psychoactive substances that are reasonably safe to use on their own can suddenly become dangerous
    19 KB (2,841 words) - 14:21, 16 April 2024
  • 2C-E (category Pages using duplicate arguments in template calls)
    Class A drug in the United Kingdom as a result of the phenethylamine catch-all clause. United States: 2C-E is a Schedule I drug. Responsible use Volumetric
    22 KB (2,969 words) - 13:42, 16 April 2024
  • Methylphenidate
    false-positives for amphetamine in drug screenings. However, there was found no immunoassay cross reactivity in laboratory study. Responsible use Stimulants Amphetamine
    31 KB (4,254 words) - 15:15, 6 May 2024
  • Promethazine
    careful when trying this pharmaceutical and use responsible use practices such as always having a tripsitter when using promethazine, especially at high doses
    12 KB (1,621 words) - 00:22, 6 May 2024
  • Adrenaline (section Drugs targeting the adrenergic system)
    settings such as a school for emergency usage or for first aid carry. Responsible use Acetylcholine Dopamine Glutamate Serotonin Noradrenaline GABA Neurotransmitter
    5 KB (628 words) - 23:12, 21 April 2024
  • 3C-P
    that one use harm reduction practices when using this substance. 3C-P is not habit-forming, and the desire to use it can actually decrease with use. It is
    11 KB (1,643 words) - 00:24, 10 May 2024
  • Barbiturates
    barbiturates after prolonged use.[citation needed] It is unknown exactly how long it takes for tolerance to reach baseline after continued use. All barbiturates present
    16 KB (1,815 words) - 09:25, 14 January 2023
  • Caffeine
    strongly recommended that one use harm reduction practices when using this substance. Caffeine produces dependence with chronic use and has a low abuse potential
    29 KB (3,603 words) - 00:00, 10 May 2024
  • 4-MeO-PCP
    recommended that one use harm reduction practices when using this drug. As with other NMDA receptor antagonists, the chronic use of 4-MeO-PCP can be considered
    13 KB (1,828 words) - 21:19, 21 July 2022
  • 4-AcO-MET
    one use harm reduction practices when using this substance. 4-AcO-MET is not habit-forming and the desire to use it can actually decrease with use. It
    14 KB (2,059 words) - 17:03, 17 March 2024
  • 4-AcO-DET
    as drug and is illegal to possess, produce, supply, or import. United Kingdom: 4-AcO-DET is a Class A drug in the UK as it is an ester of the drug 4-HO-DET
    16 KB (2,204 words) - 05:15, 30 June 2022
  • Oxycodone
    strongly recommended that one use harm reduction practices when using this drug. As with other opioids, the chronic use of oxycodone can be considered
    17 KB (2,820 words) - 14:12, 16 April 2024
  • Cannabis (section Medical use)
    1961 drug convention signed by countries from around the world. Responsible use Hallucinogens Cannabinoids Synthetic cannabinoids Cannabis (drug) (Wikipedia)
    65 KB (8,816 words) - 18:09, 27 April 2024
  • 4-HO-DPT
    strongly recommended that one use harm reduction practices when using this drug. 4-HO-DPT is not habit-forming, and the desire to use it can actually decrease
    11 KB (1,524 words) - 16:45, 29 May 2021
  • 25E-NBOH (section Drug interactions)
    process, or distribute without a license from the Drug Enforcement Administration (DEA). Responsible use Psychedelic Phenethylamines 25B-NBOH 25X-NBOH 25E-NBOH
    17 KB (2,234 words) - 18:19, 30 April 2024
  • Psilocin
    recommended that one use harm reduction practices if choosing to use this substance. Psilocin is not habit-forming, and the desire to use it can actually decrease
    40 KB (4,715 words) - 16:45, 25 January 2024
  • Memantine
    Memantine Further information: Responsible use § Hallucinogens The toxicity and long-term health effects of recreational memantine use do not seem to have been
    17 KB (2,270 words) - 05:20, 1 May 2024
  • Deschloroketamine
    Austria under the NPSV (Neue-Psychoaktive-Substanzen-Verordnung). Responsible use Designer drug Dissociative O-PCE Ketamine MXE Deschloroketamine (Wikipedia)
    16 KB (2,011 words) - 23:32, 21 April 2024
  • Ephenidine
    Schedule IV drug. However, the isomer clauses within the legal text of the Schedules have rarely, if ever, been used for prosecution. Responsible use Research
    25 KB (3,096 words) - 09:43, 10 May 2024
  • Diphenhydramine
    [citation needed] The recreational use of diphenhydramine is generally not advised. If deciding to use this substance, one should use extreme caution and harm reduction
    33 KB (4,164 words) - 20:42, 12 May 2024
  • 2M2B
    produce, supply, or import this drug under the Psychoactive Substance Act, which came into effect on May 26th, 2016. Responsible use Depressant Alcohol GHB GBL
    10 KB (1,665 words) - 19:06, 3 May 2023
  • Diphenidine
    and harm potential, and Responsible use § Hallucinogens The toxicity and long-term health effects of recreational diphenidine use do not appear to have been
    20 KB (2,560 words) - 20:28, 17 January 2024
  • 2C-I
    Toxicity and harm potential, and Responsible use § Hallucinogens The toxicity and long-term health effects of recreational 2C-I use do not seem to have been studied
    19 KB (2,571 words) - 21:32, 14 November 2023
  • Myristicin
    in the United Kingdom, however, using it recreationally or extracting the myristicin is against the law. Responsible use Deliriants Tropane alkaloids Datura
    19 KB (2,523 words) - 07:09, 16 November 2023
  • 1,4-Butanediol
    drink out of. It is strongly recommended that one use harm reduction practices when using this drug. In multiple studies, GHB has been found to impair
    19 KB (2,729 words) - 17:49, 20 March 2024
  • Dextromethorphan
    extraction Further information: Responsible use § Hallucinogens The toxicity and long-term health effects of recreational DXM use in humans has not been studied
    66 KB (8,370 words) - 12:29, 7 May 2024
  • MDA
    Netherlands United Kingdom: MDA is a class A drug.[citation needed] United States: MDA is a Schedule I drug. Responsible use Entactogen Amphetamine MDMA MDEA 6-APB
    31 KB (4,379 words) - 12:23, 6 May 2024
  • 3-MeO-PCMo
    and harm potential, and Responsible use § Hallucinogens The toxicity and long-term health effects of recreational 3-MeO-PCMo use do not seem to have been
    15 KB (2,255 words) - 21:04, 21 July 2022
  • Bufotenin
    that one use harm reduction practices when using this drug. Bufotenin is not habit-forming and the desire to use it can actually decrease with use. It is
    16 KB (2,273 words) - 19:54, 7 April 2024
  • LSD
    Zentner, Joseph L. (1976). "The Recreational Use of LSD-25 and Drug Prohibition". Journal of Psychedelic Drugs. 8 (4): 299–305. doi:10.1080/02791072.1976
    100 KB (12,100 words) - 08:20, 3 January 2024
  • Ketamine (section Caution for intravenous use)
    Category 3 drug in Mexico.[citation needed] New Zealand: Ketamine is a Class C drug in New Zealand.[citation needed] Norway: Ketamine is a Class A drug in Norway
    57 KB (7,569 words) - 21:34, 6 May 2024
  • 2-Fluorodeschloroketamine
    recommended that one use harm reduction practices when using this drug. As with other NMDA receptor antagonists, the chronic use of 2-Fluorodeschloroketamine
    17 KB (2,196 words) - 10:23, 7 May 2024
  • 4-HO-MPT
    and harm potential, and Responsible use § Hallucinogens The toxicity and long-term health effects of recreational 4-HO-MPT use do not seem to have been
    10 KB (1,423 words) - 17:12, 29 May 2021
  • Omberacetam
    medical and pharmacological effects of this officially non-drug substance. Responsible use Nootropic Stimulant Modafinil Omberacetam (Wikipedia) Omberacetam
    11 KB (1,343 words) - 23:24, 21 April 2024
  • Alprazolam
    Misuse of Drugs Act 1971 makes it illegal to possess the drug without a prescription and, for such purposes, it is classified as a Class C drug. United States:
    25 KB (3,914 words) - 14:31, 16 April 2024
  • 4-AcO-MiPT
    strongly recommended that one use harm reduction practices when using this drug. 4-AcO-MiPT is not habit-forming and the desire to use it can actually decrease
    16 KB (2,243 words) - 18:21, 19 January 2024
  • Haloperidol
    that one use harm reduction practices when using this drug. Australia: The drug is available via prescription only.[citation needed] Canada: The drug is available
    8 KB (955 words) - 03:21, 11 May 2024
  • Heroin
    alth/drug-law-reform Vancouver Insite drug-injection facility can stay open, 2011  http://scc.lexum.org/en/2011/2011scc44/2011scc44.html New drug guidelines
    27 KB (4,225 words) - 13:14, 16 April 2024

View (previous 100 | next 100) (20 | 50 | 100 | 250 | 500)

Retrieved from ‘https://psychonautwiki.org/wiki/Special:Search’